National DPP Partner Site-Level Rapid Evaluation Nomination

National Evaluation of the DP18-1815 Cooperative Agreement Program: Category A, Diabetes Management and Type 2 Diabetes Prevention

Att 4b. NDPP Site Nom Form

National DPP Partner Site-Level Rapid Evaluation Nomination

OMB: 0920-1312

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-xxxx

Exp. Date XX/XX/20XX



National DPP Site-Level Rapid Evaluation - Site Nomination Form


Please use this form to nominate two (2) National DPP lifestyle change programs (LCPs) within your state for inclusion in the site-level rapid evaluation as part of the national evaluation of DP18-1815

Your participation is voluntary. You may skip any question you do not want to answer for any reason. There are no known risks or direct benefits to you for completing this nomination form. The information you provide will help inform the selection of LCPs for the National DPP site-level rapid evaluation.  


Note: Public reporting burden of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-19BHC)


NOMINATION GUIDANCE:

Please nominated two (2) National DPP LCP sites that:

  • Are actively offering the National DPP LCP for people with diabetes

  • Have a Diabetes Prevention Recognition Program (DPRP) status of: preliminary, pending, or full

  • Are delivered either 100% in-person or combination in-person and online/distance learning (online only programs are not eligible for inclusion)

The unit of analysis for the rapid evaluation is the site. If your health department works with an organization or program offering CDC-recognized LCPs at multiple sites, please indicate a specific site to be included in the rapid evaluation. 

Consider selecting sites that have different characteristics, such as:

  • Different delivery platforms -- In-person vs. combination

  • Serve different population groups -- focus on Medicaid population vs. focus on African American population

  • Located in different geographic areas -- urban vs. rural

  • History of performance -- strong performance vs. experienced many challenges 

Your nominations will be reviewed by a CDC panel to ensure sites meet the eligibility criteria. The Deloitte National Evaluation Team will send follow up communication to confirm the inclusion of your nominated sites or request additional clarifying information. 

The nomination form will take approximately 30 minutes to complete. Nominations must be submitted no later than Month Day.

Additional information about site participation in the rapid evaluation is available in the 1815 Site-Level Rapid Evaluation FAQs. Contact [email protected] if you have any questions about this nomination form or the rapid evaluations. 


CLICK NEXT TO COMPLETE THE NOMINATION FORM


(End of Page 1)

Shape1

Health Department Information


Nominator's Name
The nominator is the person completing this form.


Nominator's Name ________________________________________

Position/Job Title ________________________________________

Phone ________________________________________

Email ________________________________________

Organization Name ________________________________________

City ________________________________________

Zip Code ________________________________________


(End of Page 2)

Shape2 1st Nominee: Site Contact Information 


 

National DPP LCP Program Name _______________________________________


If the program has multiple sites, specify the name of the individual site you nominate to participate in the rapid evaluation ________________________________________


If the program is affiliated with a larger CDC-recognized organization (i.e. YMCA), specify the name of the organization  ________________________________________


Complete the address for the National DPP LCP site that you are nominating for the rapid evaluation. If nominating a specific site, enter the information for that site.

Street Address (for the specific site where the LCP is being offered) ________________________________________

City ________________________________________

Zip Code ________________________________________

Site ID/Organization Code ________________________________________


Primary Contact Person at the site you are nominating

Primary Contact Person Name ________________________________________

Position/Job Title ________________________________________

Phone ________________________________________

Email ________________________________________

Agency/Organization ________________________________________


Alternate Contact Person at the site you are nominating 

Alternative Contact Person Name ________________________________________

Position/Job Title ________________________________________

Phone ________________________________________

Email ________________________________________

Agency/Organization ________________________________________


Is your health department currently supporting this National DPP LCP site through 1815 funds?

  • Yes, we are currently supporting this site through 1815 funds

  • No, we are in the process of establishing a contract with this site

  • No, but we are expecting to support this site in the future years of the cooperative agreement

  • Other, please specify ____________________

  • I don't know



(End of Page 3)

Shape3

1st Nominee: Site Program Information 


Please answer the following questions to provide some contextual information about the nominated site. 


What setting does the site operate in? 

  • State Government

  • Community-based organization

  • Faith-based organization

  • Pharmacy

  • Healthcare organization

  • Public employer worksite

  • Private employer worksite

  • Other, please specify ____________________

  • I don't know

Indicate whether the site provides targeted services to specific populations by answering the questions below.


Does the site have a specific focus on serving any of the following age group(s)? (select all that apply)

  • The site does not have a specific focus on any age group

  • Adults 20-24

  • Adults 25-39

  • Adults 40-49

  • Adults 50-64

  • Adults 65 & Older

  • Other age group, please specify ____________________

  • I don't know


Does the site have a specific focus on serving Hispanics/Latinos

  • Yes

  • No

  • I don't know


Does the site have a specific focus on serving the following populations? (Select all that apply)

  • The site does not have a specific focus on any racial group

  • African American or Black

  • White

  • American Indian or Alaska Native

  • Asian Indian

  • Chinese

  • Filipino

  • Japanese

  • Korean

  • Vietnamese

  • Other Asian, please specify ____________________

  • Native Hawaiian or Other Pacific Islander

  • Guamanian or Chamorro

  • Samoan

  • Other, please specify ____________________

  • I don't know


Does the site have a specific focus on serving any of the following sub-populations? (select all that apply)

  • The site does not have a specific focus on any other sub-population

  • Low socioeconomic status

  • People with disabilities, including mental health issues

  • Medicaid populations

  • Other sub-populations, please specify: ____________________

  • I don't know


What is the primary geographic region that the site serves? (Select only one)  

  • Urbanized Area (population greater than 50,000)

  • Urbanized Cluster (population greater than 2,500 less than 50,000)

  • Rural Areas (all areas not included within an urban area)

  • Other geographic area, please specify: ____________________

  • I don't know



(End of Page 4)

Shape4

1st Nominee: Health Department Collaboration with Site


To your knowledge, how long has the site been offering the CDC-recognized National DPP LCP? 

____________________


How long has your health department been supporting this site, through CDC funding?

______________________________________________________________

______________________________________________________________

______________________________________________________________


Will your health department be collecting any data from this site for the 1815 recipient-led evaluation?

  • Yes

  • No

  • I don't know


Has this site participated in previous data collection efforts with your state health department?

  • Yes

  • No

  • I don't know


(End of Page 5)

Shape5 Please specify when the evaluation was conducted (mo/yr) 

Month ________________________________________

Year  ________________________________________


Please describe the focus of the evaluation

______________________________________________________________

______________________________________________________________

______________________________________________________________



(End of Page 6)

Shape6

1st Nominee: Health Department Collaboration with Site, continued


Health Department Support - How is the Health Department supporting this site? (e.g. marketing, working with payers to expand coverage; promotion with payers, provider education on prediabetes screening, testing and referral, etc.)

______________________________________________________________

______________________________________________________________

______________________________________________________________


Which 1815-funded Category A strategies align with the support your health department is providing to this site? (select all that apply)

  • A1: Improve access to and participation in ADA-recognized/AADE-accredited DSMES program in underserved areas

  • A2: Expand or strengthen DSMES coverage policy

  • A3: Increase engagement of pharmacist in the provision of DSMES or Medication Management

  • A4: Assist HCOs to identify people with prediabetes and refer them to CDC-recognized lifestyle change programs

  • A5: Expand availability of National DPP as a covered benefit

  • A6: Increase enrollment in CDC-recognized lifestyle change programs

  • A7: Develop infrastructure to promote long-term sustainability/reimbursement for Community Health Workers (CHWs)


Please list any organizations you are collaborating with to support implementation of 1815-funded activities within this site (e.g. community-based organizations, contracted agencies, health care organizations). If you do not work with any partners, enter "N/A" in the first row. 


Organization Name

Organization Type (e.g. Health Care, Community-Based, Faith-Based)

1.

1.

2.

2.

3.

3.

4.

4.

5.

5.


Has your health department previously supported this National DPP LCP site through another funding mechanism beyond 1815 (e.g. DP13-1305, DP14-1422, state budget, other)? (select all that apply) 

  • No, our health department has not previously supported this site through another funding mechanism

  • We supported this site through DP13-1305

  • We supported this site through DP14-1422

  • We supported this site through state funding

  • Other support, please specify all other funding sources that previously supported this site: ____________________

  • I don't know


Is your health department currently supporting this National DPP LCP site through a funding mechanism beyond 1815 (e.g. DP18-1817, WISEWOMAN, state budget, other)? (select all that apply)

  • No, our health department does not currently support this site through another funding mechanism

  • We support this site through DP18-1817

  • We support this site through state funding

  • Other support, please specify all other funding sources to support this site: ____________________

  • I don't know


Please specify and describe how else you work with this National DPP LCP site?

______________________________________________________________

______________________________________________________________

______________________________________________________________

Why have you nominated this site for inclusion in the site-level rapid evaluation?

______________________________________________________________

______________________________________________________________

______________________________________________________________


What other information would you like to share about this site?

______________________________________________________________

______________________________________________________________

______________________________________________________________


(End of Page 7)

Shape7 Thank you for completing the first of two National DPP nominations for site-level rapid evaluations. Click next to submit the second nomination.


(End of Page 8)

Shape8

2nd Nominee: Site Contact Information 


 

National DPP LCP Program Name ________________________________________

If the program has multiple sites, specify the name of the individual site you nominate to participate in the rapid evaluation ________________________________________


If the program is affiliated with a larger CDC-recognized organization (i.e. YMCA), specify the name of the organization ________________________________________


Complete the address for the National DPP LCP site that you are nominating for the rapid evaluation. If nominating a specific site, enter the information for that site.


Street Address (for the specific site where the LCP is being offered) ________________________________________

City ________________________________________

Zip Code ________________________________________

Site ID/Organization Code ________________________________________


Primary Contact Person at the site you are nominating

Primary Contact Person Name ________________________________________

Position/Job Title ________________________________________

Phone ________________________________________

Email ________________________________________

Agency/Organization ________________________________________


Alternate Contact Person at the site you are nominating

Alternative Contact Person Name ________________________________________

Position/Job Title ________________________________________

Phone____________________________________

Email ________________________________________

Agency/Organization ________________________________________


Is your health department currently supporting this National DPP LCP site through 1815 funds?

  • Yes, we are currently supporting this site through 1815 funds

  • No, we are in the process of establishing a contract with this site

  • No, but we are expecting to support this site in the future years of the cooperative agreement

  • Other, please specify ____________________

  • I don't know



(End of Page 9)

Shape9

2nd Nominee: Site Program Information 


Please answer the following questions to provide some contextual information about the nominated site. 


What setting does the site operate in? 

  • State Government

  • Community-based organization

  • Faith-based organization

  • Pharmacy

  • Healthcare organization

  • Public employer worksite

  • Private employer worksite

  • Other, please specify ____________________

  • I don't know


Indicate whether the site provides targeted services to specific population by answering the questions below


Does the site have a specific focus on serving any of the following age group(s)? (select all that apply)

  • The site does not have a specific focus on any age group

  • Adults 20-24

  • Adults 25-39

  • Adults 40-49

  • Adults 50-64

  • Adults 65 & Older

  • Other age group, please specify ____________________

  • I don't know


Does the site have a specific focus on serving Hispanics/Latinos

  • Yes

  • No

  • I don't know


Does the site have a specific focus on serving the following populations? (Select all that apply)

  • The site does not have a specific focus on any racial group

  • African American or Black

  • White

  • American Indian or Alaska Native

  • Asian Indian

  • Chinese

  • Filipino

  • Japanese

  • Korean

  • Vietnamese

  • Other Asian, please specify ____________________

  • Native Hawaiian or Other Pacific Islander

  • Guamanian or Chamorro

  • Samoan

  • Other, please specify ____________________

  • I don't know


Does the site have a specific focus on serving any of the following sub-populations? (select all that apply)

  • The site does not have a specific focus on any other sub-population

  • Low socioeconomic status

  • People with disabilities, including mental health issues

  • Medicaid populations

  • Other sub-populations, please specify: ____________________

  • I don't know


What is the primary geographic region that the site serves? (Select only one)  

  • Urbanized Area (population greater than 50,000)

  • Urbanized Cluster (population greater than 2,500 less than 50,000)

  • Rural Areas (all areas not included within an urban area)

  • Other geographic area, please specify: ____________________

  • I don't know



(End of Page 10)

Shape10

2nd Nominee: Health Department Collaboration with Site


To your knowledge, how long has the site been offering the CDC-recognized National DPP LCP? 

____________________


How long has your health department been supporting this site, through CDC funding?

______________________________________________________________

______________________________________________________________

______________________________________________________________


Will your health department be collecting any data from this site for the 1815 recipient-led evaluation?

  • Yes

  • No

  • I don't know


Has this site participated in previous data collection efforts with your state health department?

  • Yes

  • No

  • I don't know



(End of Page 11)

Shape11 Please specify when the evaluation was conducted (mo/yr) 

Month  ________________________________________

Year  ________________________________________


Please describe the focus of the evaluation

______________________________________________________________

______________________________________________________________

______________________________________________________________



(End of Page 12)

Shape12

2nd Nominee: Health Department Collaboration with Site, continued


Health Department Support - How is the Health Department supporting this site? (e.g. marketing, working with payers to expand coverage; promotion with payers, provider education on prediabetes screening, testing and referral, etc.)

______________________________________________________________

______________________________________________________________

______________________________________________________________


Which 1815-funded Category A strategies align with the support your health department is providing to this site? (select all that apply)

  • A1: Improve access to and participation in ADA-recognized/AADE-accredited DSMES program in underserved areas

  • A2: Expand or strengthen DSMES coverage policy

  • A3: Increase engagement of pharmacist in the provision of DSMES or Medication Management

  • A4: Assist HCOs to identify people with prediabetes and refer them to CDC-recognized lifestyle change programs

  • A5: Expand availability of National DPP as a covered benefit

  • A6: Increase enrollment in CDC-recognized lifestyle change programs

  • A7: Develop infrastructure to promote long-term sustainability/reimbursement for Community Health Workers (CHWs)


Please list any organizations you are collaborating with to support implementation of 1815-funded activities within this site (e.g. community-based organizations, contracted agencies, health care organizations). If you do not work with any partners, enter "N/A" in the first row. 


Organization Name

Organization Type (e.g. Health Care, Community-Based, Faith-Based)

1.

1.

2.

2.

3.

3.

4.

4.

5.

5.



Has your health department previously supported this National DPP LCP site through another funding mechanism beyond 1815 (e.g. DP13-1305, DP14-1422, state budget, other)? (select all that apply) 

  • No, our health department has not previously supported this site through another funding mechanism

  • We supported this site through DP13-1305

  • We supported this site through DP14-1422

  • We supported this site through state funding

  • Other support, please specify all other funding sources that previously supported this site: ____________________

  • I don't know


Is your health department currently supporting this National DPP LCP site through a funding mechanism beyond 1815 (e.g. DP18-1817, WISEWOMAN, state budget, other)? (select all that apply)

  • No, our health department does not currently support this site through another funding mechanism

  • We support this site through DP18-1817

  • We support this site through state funding

  • Other support, please specify all other funding sources to support this site: ____________________

  • I don't know


Please specify and describe how else you work with this National DPP LCP site?

______________________________________________________________

______________________________________________________________

______________________________________________________________


Why have you nominated this site for inclusion in the site-level rapid evaluation?

______________________________________________________________

______________________________________________________________

______________________________________________________________


What other information would you like to share about this site?

______________________________________________________________

______________________________________________________________

______________________________________________________________



(End of Page 13)

Shape13 Thank you for completing the National DPP nominations for site-level rapid evaluation! 


(End of Page 14)

Shape14

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorGranow, Nina
File Modified0000-00-00
File Created2021-01-14

© 2024 OMB.report | Privacy Policy